Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

BNGO.Q

Miraculous Microchip   Yes, you read that right. Earlier this week, German Aldana Zuniga got behind the wheel of an 850 horsepower NASCAR Cup race car. At first glance, this…
Smart Watch, Healthy Heart   There was an opportunity for a pun in the headline and I took it. In this week’s sector roundup, we are going to be…
Sector Summary The medical sector is a doozy. From cancer to cardiovascular diseases, areas of high unmet medical need are appearing faster than they can be dealt with. According…
In this episode, we look at a life sciences instrumentation company in the genome analysis space called Bionano Genomics (BNGO.Q). The company develops and markets the Saphyr system, a…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Bionano Genomics operates as a life sciences instrumentation company in the genome analysis space that provides tools and services based on their Saphyr system to scientists and clinicians conducting…
Bionano Genomics (BNGO.Q) has been keeping busy lately, and the Company’s Q2 2021 Financial Results are a testament to their efforts.   Bionano has been on my radar for…
Bionano Genomics (BNGO.Q) is a disruption play. The company is a structural variation company focusing on the next generation of cytogenomics with optical genome mapping.     For in…
Bionano Genomics (BNGO.Q) has released a summary of results obtained by the University Hospitals Leuven, Belgium utilizing Saphyr® System, the Company’s Optical Genome Mapping (OGM) platform. The work completed…
Bionano Genomics (BNGO.Q) announced today that optical genome mapping (OGM), utilizing the Company’s Saphyr System, has revealed new insights and prognostic capabilities compared to traditional cytogenetics techniques in several…